Iodide

Iodide

SCHEMBL3908349

C1=C\C=C/c2ncccc2\C=C/1.I

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
S100A4 P26447 1/20 0.33
CDC25B P30305 1/20 0.33
TDP1 Q9NUW8 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TDP2 O95551 1/20 0.32
NSD2 O96028 1/20 0.32
ABL1 P00519 1/20 0.32
PLCG1 P19174 1/20 0.32
CES1 P23141 1/20 0.32
PAX8 Q06710 1/20 0.32
RIN1 Q13671 1/20 0.32
THRB P10828 1/20 0.32
BLM P54132 1/20 0.32
GAA P10253 1/20 0.32
KDM4E B2RXH2 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL3908355 1.00 CA12 (0.41) CA12CA1CA2CA9S100A4
SCHEMBL1648800 0.98 CA12 (0.42) CA12CA1CA2CA9S100A4
SCHEMBL1648797 0.98 CA12 (0.42) CA12CA1CA2CA9S100A4
SCHEMBL27847095 0.95 CA12 (0.41) CA12CA1CA2CA9S100A4
SCHEMBL3261185 0.80
SCHEMBL4866082 0.79
SCHEMBL7056574 0.73 CDC25B (0.41) CA12CA1CA2CA9S100A4
SCHEMBL21319387 0.73 CDC25B (0.41) CA12CA1CA2CA9S100A4
SCHEMBL7056579 0.73 CDC25B (0.41) CA12CA1CA2CA9S100A4
SCHEMBL23330240 0.71 CA12 (0.44) CA12CA1CA2CA9S100A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531008-B2 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor L'OREAL S.A. (FR) 2009-05-12 US disclosed
US-20070143936-A1 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor L'OREAL S.A. (FR) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070143936-A1 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor KRT18, HKDC1, DSC1 CA12 856/4885CA1 2391/4885CA2 1608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.